Synthesis and cytotoxicity of 6,11-Dihydro-pyrido- and 6,11-Dihydro-benzo[2,3-b]phenazine-6,11-dione derivatives

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 8, 2003, Pages 1709-1714

  Kim, Young Shin ^a   Park, Se Young ^a   Lee, Hyun Jung ^a   Suh, Myung Eun ^a   Schollmeyer, Dieter ^b   Lee, Chong Ock ^c  

^a Ewha Womans University   (South Korea)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6,11 DIHYDRO 3 ETHOXYPYRIDO[2,3 B]PHENAZINE 6,11 DIONE; 6,11 DIHYDRO 3 ISOPROPOXYPYRIDO[2,3 B]PHENAZINE 6,11 DIONE; 6,11 DIHYDRO 3,4 DIMETHYLPYRIDO[2,3 B]PHENAZINE 6,11 DIONE; ANTINEOPLASTIC AGENT; PHENAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; COLON CANCER; COLUMN CHROMATOGRAPHY; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LUNG CANCER; MELANOMA; NERVE CELL; OVARY TUMOR; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

EID: 0037378176     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00028-2     Document Type: Article

References (22)

1. Rao K.V., Cullen W.P. Antibiot. Ann. 1959-1960:1960;950.
2. Ebert P.S., Chirigos M.A., Ellsworth P.A. Cancer Res. 28:1968;363.
3. Kaung D.T., Whittington R.M., Spencer H.H., Patno M.E. Cancer. 23:1969;597.
4. Lown, J. W. In The Molecular Mechanism of Antitumor Action of the Mitomycins in Mitomycin C, Current Status and New Developments; Carter, S. T.; Crooke, S. T., Eds.; Academic: Orlando, FL, 1979; pp 5-26.
5. Shaikh I.A., Johnson F., Grollmann A.P. J. Med. Chem. 29:1986;1329.
6. Suh M.E., Kang M.J., Yoo H.W., Park S.Y., Lee C.O. Bioorg. Med. Chem. 8:2000;2079.
7. Suh M.E., Park S.Y., Lee C.O. Bioorg. Med. Chem. 9:2001;2979.
8. Denny, W. A.; Bagulet, B. C. In Molecular Aspects of Anticancer Drug-DNA Interactions, 2nd ed.; Waring, M. J.; Neidle. S., Eds.; Macmillan: London, 1994; pp 270-311.
9. Pommier Y., Capranico G., Orr A., Kohn K.W. Nucleic Acids Rep. 19:1991;5973.
10. Fosse P., Rene B., Le Bret M.C., Paoletti C., Saucier J.M. Nucleic Acids Rep. 19:1991;2861.
11. Lin A.J., Lillis B.J., Sartorelli A.C. J. Med. Chem. 18:1975;917.
12. Yamashita Y., Kawada S., Fujii N., Nakano H. Cancer Res. 50:1990;5841.
13. Beall H.D., Siegel D., Liu Y., Bolton E.M., Gibson N.W., Ross D. Biochem. Pharmacol. 51:1996;645.
14. Moore M.H., Hunter W.H., Kennard O.J. J. Mol. Biol. 206:1987;693.
15. Pindur U., Haber M., Sattler K. J. Chem. Educ. 70:1993;263.
16. Suh M.E., Shin S.H. Yakhak Hoeji. 41(5):1997;575.
17. Altomare A., Cascarano G., Giacovazzo C., Guagliardi A., Burla M.C., Polidori G., Camalli M. J. Appl. Cryst. Part 3. 27:1994;435.
18. Sheldrick, G. M. Program for Crystal Structure Refinement; University of Goettingen, Germany, 1993.
19. Keller, E. A computer program for the graphic representation of molecular and crystallographic models; University of Freiburg, Germany, 1992.
20. Yanni A.S., Indian J. Chem., Sec. B. 30B(8):1991;808.
21. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J.B., Vistica D.T., Warren J.T., Bokesc H., Kenney S., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1107.
22. Rubinstein L.V., Shoemaker R.H., Paull K.D., Simon R.M., Tosini S., Skehan P., Scudiero D., Monks A., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1113.